Telehealth Therapy for Stroke
Trial Summary
What is the purpose of this trial?
The goal of this clinical trial to test whether a remotely delivered behavioral activation-based intervention called "teleABLE" works better than a health education intervention for (1) reducing sitting time and (2) improving health-related quality among adults who were diagnosed with stroke within the past 12 months. Participants in this study will: * Complete questionnaires at Weeks 1, 8, and 24 * Wear an activPAL monitor at Weeks 1, 8, and 24 * Participate in the teleABLE intervention (12 sessions) or the health education intervention (6 sessions) * Complete an interview at Week 24
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment teleABLE for stroke?
Research shows that telerehabilitation, which includes remote therapy and feedback, can improve access to therapy for stroke survivors and enhance their recovery. Additionally, virtual reality and gaming-based interventions have been found effective in improving upper limb function after a stroke, suggesting that similar telehealth approaches like teleABLE could be beneficial.12345
Is telehealth therapy for stroke generally safe for humans?
How is the teleABLE treatment for stroke different from other treatments?
The teleABLE treatment is unique because it uses telehealth to deliver therapy, focusing on activating behavior for lasting engagement, which may improve access and adherence to rehabilitation for stroke survivors. This approach is different from traditional in-person therapy by providing remote, continuous support and potentially enhancing patient engagement and self-management.12101112
Research Team
Emily Kringle, PhD, OTR/L
Principal Investigator
University of Minnesota
Eligibility Criteria
This trial is for adults who had a stroke within the last year. They should be able to complete questionnaires, wear an activity monitor, and attend telehealth sessions. Specific details on what conditions exclude someone from participating are not provided.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either the teleABLE intervention (12 sessions) or the health education intervention (6 sessions) over 6 weeks
Follow-up
Participants complete questionnaires and wear an activPAL monitor at Weeks 1, 8, and 24, and complete an interview at Week 24
Treatment Details
Interventions
- teleABLE
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Minnesota
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator